TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/17/2026 01:54 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $27.45. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $4,095,925 vs put $0. RSI 26.0.
- Symbol
- ACAD
- Price
- $27.45
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-17 13:54:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume: 100% call volume, indicating strong bullish conviction.
The pure directional positioning suggests near-term bullish expectations.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 12.35 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.26 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports increased sales for its flagship product.
- Analysts upgrade ACAD's rating due to strong quarterly performance.
These headlines suggest positive developments for ACAD, potentially impacting its stock price. The FDA approval and increased sales could be significant catalysts, while the analyst upgrade adds to the positive sentiment.
Fundamental Analysis:
Based on the provided fundamentals:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 12.35
- Price-to-Book: 7.26
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
The company shows a strong ROE and a reasonable P/E ratio. However, the debt-to-equity ratio is relatively low, which could indicate a conservative approach to leverage. The fundamentals suggest a stable financial position, but the lack of revenue growth data makes it difficult to assess the company's growth trajectory.
Current Market Position:
Current price: $27.45
Recent price action shows a slight decline, with the stock trading near its lower range.
Support levels: around $26.64 (recent low)
Resistance levels: around $28.50 (recent high)
Technical Analysis:
Technical Indicators
The RSI indicates oversold conditions, while the MACD shows a bearish signal. The 50-day SMA is slightly above the current price, indicating a neutral to slightly bearish trend.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume: 100% call volume, indicating strong bullish conviction.
The pure directional positioning suggests near-term bullish expectations.
Key Price Levels:
25-Day Price Forecast:
Based on current trends and indicators:
ACAD is projected for $25.50 to $28.00
Rationale: The current RSI suggests oversold conditions, and if the trend reverses, the stock could move towards the 50-day SMA. Resistance levels and recent highs could act as targets or barriers.
Defined Risk Strategy Recommendations:
Based on the projected price range:
- Buy Call Spreads: ACAD 261016C00026000 (26 strike) and ACAD 261016C00028000 (28 strike)
- Sell Put Spreads: ACAD 261016P00024000 (24 strike) and ACAD 261016P00026000 (26 strike)
- Iron Condor: ACAD 261016C00026000, ACAD 261016C00027000, ACAD 261016P00024000, ACAD 261016P00025000
These strategies align with the bullish sentiment and offer defined risk.
Risk Factors:
- Technical weaknesses: RSI and MACD indicate bearish trends.
- Sentiment divergences: None apparent.
- Volatility: Recent ATR suggests moderate volatility.
Caution is advised as technical indicators show mixed signals.
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: Consider bullish strategies on ACAD given the sentiment and technical setup.
View ACAD Options Chain